API Holdings Limited formerly known as API Holdings Private Limited is an unlisted public limited company, incorporated on 31st March 2019.
API Holdings Limited is India's largest digital healthcare platform in terms of the gross merchandise value (GMV) of products and services sold.
The Company is engaged in diversified businesses primarily trading pharmaceutical and cosmetic goods, licensing of internet portals or mobile applications related to sales and distribution of pharmaceutical and cosmetic goods, diagnostic services, teleconsulting, etc.
API Holdings Ltd, the parent company of online pharmacy and health tech platform PharmEasy, which recently withdrew its IPO due to "market conditions and external factors”, recorded a larger loss for FY22 than the previous year. Pharmeasy share price has grown from a distributor of medicinal products to a fully integrated, digital healthcare platform that offers teleconsultation, medical equipment, and pharmaceuticals.
|
PharmEasy Outstanding Shares: |
5,530,566,129 |
|
Face Value of PharmEasy Unlisted Share: |
Rs. 1 Per Equity Share |
|
ISIN of PharmEasy Unlisted Share: |
INE0DJ201029 |
|
Lot Size of PharmEasy Unlisted Share: |
1000 Shares |
|
PharmEasy Share Price: |
Best in Industry |
|
PAN Number of PharmEasy: |
AASCA1201E |
PharmEasy CIN Number |
U60100MH2019PLC323444 |
PharmEasy Registration Date |
31-Mar-19 |
Category / Sub-Category of PharmEasy |
Limited by Shares/ Non-govt company |
PharmEasy Registered Office Address |
Unit No 104, Marwahs Complex 4, Marwah Estate, Krishnalal, Marwah Marg, Mumbai - 400072 |
PharmEasy Registrar & Transfer Agent Address and Contact Details |
Link InTime India Private Limited, 902, 9TH Floor, Raheja Plaza 1, B Wing, Opposite R City Mall, L.B.S Marg, Ghatkopar, Mumbai - 400086 |
Mr. Aditya Puri, Chairman, Non-Executive Director
Mr. Deepak Vaidya, Independent, Non-Executive Director
Mr. Ankur Thadani, Non-Executive Director
Mr. Ashutosh Sharma, Non-Executive Director
Ms. Vineeta Rai, Independent, Non-Executive Director
Dr. Jaydeep Tank, Independent, Non-Executive Director
Mr. Subramaniam Somasundaram, Independent, Non-Executive Director
Mr. Siddharth Shah, MD, and CEO
Mr. Harsh Parekh, Whole-time Director
Mr. Dharmil Sheth, Whole-time Director
| . No. | Name of the Company | Holding/ Subsidiary/ Associate | % of Shares held |
|
1. |
Threpsi Solutions Private Limited |
Subsidiary |
100 |
|
2. |
ARZT and Health Private Limited |
Subsidiary |
100 |
|
3. |
Ascent Wellness and Pharma Solutions Private Limited |
Subsidiary |
100 |
|
4. |
Docon Technologies Private Limited |
Subsidiary |
100 |
|
5. |
Thyrocare Technologies Limited |
Subsidiary |
71.18 |
|
6. |
AKP Healthcare Private Limited |
Subsidiary |
51 |
|
7. |
Ayro Retail Solutions Private Limited |
Subsidiary |
100 |
|
8. |
Venkatesh Medico Private Limited |
Subsidiary |
51 |
|
9. |
Instinct Innovations Private Limited |
Subsidiary |
100 |
|
10. |
Eastern Agencies Healthcare Private Limited |
Subsidiary |
100 |
|
11. |
MARG ERP Ltd |
Associate |
99.23 |
|
12. |
Equinox Labs Limited |
Associate |
209.2 |
|
13. |
Impex Healthcare Private Limited |
Associate |
90.30 |
According to a Red Seer Report, the company has a target addressable market of Rs. 10.4 trillion ($139 billion) as of 2020, which corresponds to the size of the entire Indian Healthcare market in 2020. The target addressable market is expected to grow at a 14% CAGR to reach $20 trillion ($266 billion) by 2025.
Online pharmacy-led play: Online pharmacies, consisting of at-home delivery of prescription medicines, covered 63% of the market pre-COVID in 2019 and held 55% of the market in 2020, despite the disruption in pharma supply. eOTC is the second-largest segment, constituting doorstep delivery of generic medicines and health products. It accounted for 26% of the market share before COVID, which soared to 35% in 2020, owing to the high demand for COVID-related OTC products.
Large headroom ahead: Despite the high growth, digital penetration in health (across pharma, OTC, diagnostics, and consultation) is only at 2%, indicating a very nascent stage of penetration. For example, online pharmacy penetration in India was 2.3% in 2020, significantly lower than in China (10-15%) and the United States (30-35%).
A.1 PharmEasy is preparing to launch its IPO.
A.2 One can buy PharmEasy shares online through our website, or investors can call us and confirm the deal with our Relationship Manager at 966999944, 7999252591, or 0731-4025544.
A.3 No, the company has not yet been profitable because PharmEasy suffered a loss of 39,924.96 million in FY 2022.
A.4 Pharmeasy share price used to change every day like other companies ' share prices. To find out the most recent Phrameasy share price contact us
Q5) Buying Pharmeasy Pre IPO shares is legal in india or not ?
Ans) Yes, Buying and Selling Pharmeasy Pre IPO shares is absolutely 100 % legal in India, since the whole transaction process
is regulated and governed by Securities and Exchange Board of India (SEBI).
Q6) What is the duration of lock in period in the case of selling Pharmeasy Pre IPO Shares?
Ans) In the case of selling , the duration of lock in period is 6 months from the date of listing of Pharmeasy IPO for retail investors
Q7)What is the use of DIS in selling Pharmeasy Pre IPO Shares?
Ans) The investors are required to fill the DIS (Delivery instruction slip) and submit to their broker. The mandatory fields in
the DIS includes :
a)ISIN no.of Pharmeasy Pre IPO Shares
b)name of the pharmeasy Pre IPO Share
c)total selling quantity of Pharmeasy Pre IPO shares
d) DP ID and client ID
e) off market annexure
Q8) How to track news updates about Pharmeasy Pre IPO Shares?
Ans) For tracking news updates about Pharmeasy Pre IPO shares you can simply visit our website news section https://wwipl.com/news
to get the latest updates about Pharmeasy Pre IPO shares.
Q9) How much time is required to credit the Pharmeasy Pre IPO Shares into the Demat Account?
Ans) The Pharmeasy Pre IPO shares credited will be reflected in T + 1 Day in the respective clients' demat account.
Q10) What is the minimum required amount for making investments in Pharmeasy Pre IPO shares?
Ans) The minimum required amount for investing in Pharmeasy Pre IPO Shares is 10000 Rupees.
